Posted by: APO | 3 March 2020

International research partnership and European & Developing Countries Clinical Trials Partnership (EDCTP) to invest €44m in next-generation antimalarials to combat drug-resistant malaria in Africa

EDCTP (https://www.EDCTP.org/) grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV (https://www.MMV.org/), Novartis (https://www.Novartis.com/) and other partners will provide an additional €22 million; The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and… Read more on https://africa-newsroom.com/press/international-research-partnership-and-european-and-developing-countries-clinical-trials-partnership-edctp-to-invest-euro44m-in-nextgeneration-antimalarials-to-combat-drugresistant-malaria-in-africa?lang=en


Categories

%d bloggers like this: